BIOT Spotlight: Biotech Entrepreneurship

Leveraging public-private partnerships for cross-sector development acceleration

Sunday 3/17/2024, 2:00 – 5:00 PM

Tapping into commercial expertise from established organizations may be the key to accelerating your early-stage development efforts. During this session you’ll hear from the Director of BLUE KNIGHT™, a joint-initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), about how innovators can leverage cross-sector expertise from established pharmaceutical and government organizations to advance their potential solutions. Join us as we engage with an industry expert to shed light on best practices for advancing your research with established organizations, avenues for obtaining funding and support, and insights into how to successfully develop and position multi-use technologies on the path to commercialization.

Examining unconventional funding avenues to support early-stage innovation

Monday 3/18/2024, 2:00 – 5:00 PM

For early-stage companies, finding nimble approaches to make large impacts on development milestones with limited funds is crucial to accelerating research efforts and remaining competitive. During this session you’ll hear from two early-stage companies who are part of BLUE KNIGHT™, a joint-initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), and innovation leaders on alternative pathways to advance early-stage innovation aside from standard investment opportunities. Join us as we examine unconventional funding opportunities such as venture backed NewCo resources, disease society partnerships, and more.